Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osmotica Pharmaceutical

Osmotica Pharmaceutical?uq=kzBhZRuG
2000 FOUNDED
M&A STATUS
Debt Refin. LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of specialty pharmaceutical products and services. The company offers generic pharmaceutical products by using osmotic technology platform and also offers portfolio of products in various stages of development focused on the treatment of movement disorders, central nervous system and neurology-based therapeutic drugs thus addressing the growing need of the global patient population.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Primary Office
  • 895 Sawyer Road
  • Marietta, GA 30062
  • United States

+1 (770) 000-0000

Osmotica Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Einhorn Chief Financial Officer
Brian Markison Chief Executive Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »